GoldenGolden
VI Partners

VI Partners

A venture capital and private equity firm investing in healthcare, biotechnology, and software companies.

All edits by  Dawson Sewell 

Edits on 15 Nov, 2019
Dawson Sewell
Dawson Sewell edited on 15 Nov, 2019
Edits made to:
Infobox (+4 properties)
Description (+106/-7 characters)
Article (+1385 characters)
Topic thumbnail

VI Partners

Company

A venture capital and private equity firm investing in healthcare, biotechnology, and software companies.

Article

VI Partners is a venture capital and private equity firm investing in healthcare, biotechnology, and software companies that is headquartered in Altendorf, Switzerland and was founded in 2001 by Alain Nicod, Arnd Kaltofen, Daniel Gutenberg, and Diego Braguglia. The firm took over the advisory of the Venture Incubator Fund when the company was founded in 2001. The Venture Incubator Fund was created in 2000 by its two strategic partners McKinsey & Company and the Swiss Federal Institute of Technology in Zurich (ETHZ). The purpose of the fund is to support startup companies based in Switzerland. Shareholders of the Venture Incubator Fund are ABB, Sulzer, Schindler, Hilti, Zurcher Kantonalbank, Suva, Buhler, Novartis, Credit Suisse, and Nestle.

Investments

VI Partners typically invests in early and growth-stage biotechnology, healthcare, and software companies. According to Pitchbook (as of November 2019) the firm has made 91 investments, has 24 companies in its portfolio, and has made 29 exits. Notable investments made by VI Partners include: Avalon Photonics, Deal United, EpiSpeed, Hybris Software, Mesa Imaging, Mila, Nexthink, PicoDRILL, Visonys, Activaero, Endoart Medical Technologies, Endo Sense, Neocutis, Neogym, Oncalis, Spinelab, Thommen Medical, Xigen, Edimer, Kuros Biosciences, Ventaleon, Gamaya, Ledgy, Myotest, Senbiosys, Sonic Emotion, and Smart Valor.

Infobox
Location
Altendorf (Sebnitz)
Full address
Bahnhofstrasse 1, Altendorf, Schwyz 8852, CH
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.